ACHC Acadia Healthcare Company, Inc.

bullish track record → $27.84 +0.84 (+3.1%)
Get emailed when ACHC changes direction
Mkt Cap $2B 52wk $11.43 - $28.48 Earnings 2026-04-29 46d ago
Est. revisions: +0.0% (3 up, 6 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -0.9)

Factor Model

net -0.9 2.4 / 10
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-0.6
Narrative Gap
+0.0

Q4 beat lifts shares 23.5% on strong execution

Watch: Watch for forward guidance and whether management raises 2026 outlook in the earnings call. Confirmation that the Q4 beat reflects structural improvement — not just one-time tailwinds — will determine if this pop holds or fades into the next correction.

Acadia Healthcare delivered a clean earnings beat across both lines in Q4. EPS of $0.07 exceeded consensus by one penny, while revenue of $821.5 million topped expectations by $21.4 million. The market responded immediately with a 23.5% jump in stock price, signaling renewed confidence in the company's operational momentum.

A beat on revenue and earnings in a tight timeframe proves management can execute against Wall Street expectations. The sharp one-day pop suggests either previous pessimism was overblown or the beat genuinely surprised. Either way, ACHC has reclaimed momentum heading into 2026 — a crucial signal for a healthcare provider dependent on consistent operational delivery.

Evidence

3d ago UBS main ACHC: Buy → Buy
46d ago Acadia Healthcare Posts Upbeat Q4 Earnings, Joins Circle Internet, Resideo Technologies And Other Big Stocks Moving Higher On Wednesday benzinga
Fundamentals & Data ▾
Acadia Healthcare Company, Inc. Healthcare · Medical Care Facilities
Mkt Cap
$2B
Beta
0.71
52w Range
$11.43 - $28.48
Short Interest
25.1M 42.08%
Days to Cover
6.5 -23%
Technicals downtrend
from 52w Hi
0.0%
1w return
+4.9%
Insiders
mixed 0B / 0S
Analysts
mixed
EPS Estimate
$0.26 +0.0% 30d 3up / 6dn
Est. Dispersion
32% 13 analysts
Analyst Target
$23 $13 - $31
Options P/C
0.15
Fund Convergence
strong D.E. Shaw, Citadel, Two Sigma, Bridgewater
Financials
Revenue
$821M +6% YoY
FCF
$-179M
Gross Margin
96%
Op Margin
6%
Momentum: decelerating
Top Holders
D.E. Shaw $167M
Citadel $20M
Two Sigma $6M
Bridgewater $2M
Recent Filings & Data
insider trade 32
net selling
15 insiders · 32 transactions (30d)
Recent transactions
YOUNG TODD S · award
CANCELMI DANIEL J · award
YOUNG TODD S · award
BERNHARD JASON R. · award
HARRIS PATRICE A. · award
FUCCI MICHAEL J. · award
KELLY RALPH DAVID · award
GRIECO WILLIAM F · award
WAUD REEVE B · award
MIQUELON WADE D · award
GREGG VICKY B · award
BISSELL E PEROT · award
KHAN NASSER · award
FARLEY BRIAN P · award
HUNTER CHRISTOPHER H · award
DIXON HEATHER BRIANNE · award
FARLEY BRIAN P · award
HUNTER CHRISTOPHER H · award
DIXON HEATHER BRIANNE · award
FARLEY BRIAN P · award
HUNTER CHRISTOPHER H · award
DIXON HEATHER BRIANNE · award
BERNHARD JASON R. · award
HARRIS PATRICE A. · award
FUCCI MICHAEL J. · award
KELLY RALPH DAVID · award
GRIECO WILLIAM F · award
WAUD REEVE B · award
MIQUELON WADE D · award
GREGG VICKY B · award
BISSELL E PEROT · award
FARLEY BRIAN P · award
2 signals · latest 3d ago

Get alerted when ACHC changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →